High-dose chemotherapy (HDC) followed by autologous stem cell transplant (ASCT) for recurrent/progressive CNS lymphoma.
Welch M, Sauter C, Matasar M, Moskowitz C, Omuro A. High-dose chemotherapy (HDC) followed by autologous stem cell transplant (ASCT) for recurrent/progressive CNS lymphoma. Journal Of Clinical Oncology 2012, 30: 2089-2089. DOI: 10.1200/jco.2012.30.15_suppl.2089.Peer-Reviewed Original ResearchHigh-dose chemotherapyNon-Hodgkin lymphomaAutologous stem cell transplantHDC-ASCTPrimary CNS lymphomaCNS lymphomaRecurrent primary CNS lymphomaRefractory non-Hodgkin lymphomaSystemic non-Hodgkin lymphomaCytarabine-based regimensHigh-dose MTXStem cell transplantTime of recurrenceFebrile neutropeniaHD-ASCTInduction regimensCNS involvementCNS recurrenceCell transplantInitial presentationInitial treatmentR-EPOCHRetrospective reviewSalvage approachCNS disease